Zyclara

Zyclara (Imiquimod) is a topical cream used to treat skin conditions like actinic keratosis and superficial basal cell carcinoma. This immune response modifier helps stimulate the body's natural defenses. Suitable for adults, it is applied directly to affected areas as directed.

Zyclara (Imiquimod) is primarily used to treat actinic keratosis, a rough, scaly patch on the skin caused by sun exposure. It is also prescribed for superficial basal cell carcinoma, a common form of skin cancer. The medication works by activating the immune system to target abnormal skin cells.

Users may notice redness, itching, or burning at the application site, which is a common response to treatment. Some individuals experience flaking, scabbing, or swelling as the skin reacts to the medication. These effects typically indicate the immune system is engaging with the treated area.

Avoid applying Zyclara to open wounds, sunburned skin, or areas with eczema. Keep the medication away from the eyes, lips, and nostrils to prevent irritation. Wash hands thoroughly before and after application to avoid unintended spread to other areas.

No significant drug interactions have been reported with Zyclara. However, avoid using other topical medications on the same area unless directed by a healthcare provider. Combining treatments may increase skin irritation or reduce effectiveness.